Name:
Osteogenesis Imperfecta
Description:
Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid (TOPaZ)
Stage:
Closed
Principal Investigator:
Prof Rachel Crowley
Sponsor:
University of Edinburgh
Network Partners
Osteogenesis Imperfecta
Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid (TOPaZ)
Closed
Prof Rachel Crowley
University of Edinburgh